Bvf Inc Arcus Biosciences, Inc. Transaction History

Bvf Inc

  • $3.15 Billion
  • Q3 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$19.7 - $35.71 $8.15 Million - $14.8 Million
-413,500 Reduced 15.22%
2,303,520 $47.6 Million
Q3 2022

Nov 14, 2022
SELL
$23.23 - $30.07 $28.9 Million - $37.4 Million
-1,243,928 Reduced 31.4%
2,717,020 $71.1 Million
Q1 2022

May 16, 2022
BUY
$28.92 - $41.83 $16.3 Million - $23.5 Million
562,881 Added 16.56%
3,960,948 $125 Million
Q4 2021

Feb 14, 2022
BUY
$31.38 - $48.47 $5.28 Million - $8.15 Million
168,245 Added 5.21%
3,398,067 $138 Million
Q3 2021

Nov 15, 2021
BUY
$26.93 - $37.68 $11.6 Million - $16.3 Million
432,000 Added 15.44%
3,229,822 $113 Million
Q2 2021

Aug 16, 2021
BUY
$22.75 - $35.77 $21 Million - $33 Million
921,700 Added 49.13%
2,797,822 $76.8 Million
Q1 2021

May 17, 2021
SELL
$26.16 - $41.39 $22.9 Million - $36.3 Million
-876,100 Reduced 31.83%
1,876,122 $52.7 Million
Q4 2020

Feb 12, 2021
BUY
$17.0 - $32.36 $2.64 Million - $5.02 Million
155,000 Added 5.97%
2,752,222 $71.4 Million
Q3 2020

Nov 13, 2020
BUY
$17.14 - $25.47 $12.2 Million - $18.2 Million
714,500 Added 37.95%
2,597,222 $44.5 Million
Q2 2020

Aug 14, 2020
BUY
$13.97 - $36.56 $25.8 Million - $67.4 Million
1,844,148 Added 4780.81%
1,882,722 $46.6 Million
Q1 2020

May 15, 2020
SELL
$8.78 - $19.28 $31.1 Million - $68.3 Million
-3,540,449 Reduced 98.92%
38,574 $535,000
Q3 2019

Nov 14, 2019
BUY
$6.44 - $10.18 $282,072 - $445,884
43,800 Added 1.24%
3,579,023 $32.6 Million
Q2 2019

Aug 14, 2019
BUY
$7.29 - $13.38 $5.29 Million - $9.7 Million
725,000 Added 25.8%
3,535,223 $28.1 Million
Q1 2019

May 15, 2019
BUY
$8.95 - $12.49 $3.57 Million - $4.98 Million
398,600 Added 16.53%
2,810,223 $35.1 Million
Q4 2018

Feb 14, 2019
BUY
$9.74 - $14.5 $13.2 Million - $19.6 Million
1,352,783 Added 127.76%
2,411,623 $26 Million
Q3 2018

Nov 14, 2018
BUY
$10.88 - $14.95 $1.08 Million - $1.48 Million
99,000 Added 10.31%
1,058,840 $14.8 Million
Q2 2018

Aug 14, 2018
SELL
$12.24 - $17.05 $3.79 Million - $5.28 Million
-309,948 Reduced 24.41%
959,840 $11.7 Million
Q1 2018

May 07, 2018
BUY
$15.44 - $17.71 $19.6 Million - $22.5 Million
1,269,788 New
1,269,788 $19.6 Million

Others Institutions Holding RCUS

# of Institutions
200
Shares Held
51.5M
Call Options Held
236K
Put Options Held
141K
View Full List

About Arcus Biosciences, Inc.

RCUS Quotes by TradingView
  • Ticker RCUS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,160,000
  • Market Cap $1.02B
  • Description
  • Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...
More about RCUS
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email